Press "Enter" to skip to content

Month: March 2020

Hemopure (HBOC-201) Addresses the Serious Threat Posed to US Blood Supplies by the Emerging Infectious Diseases

Ensuring a regular and quality blood supply is a constant challenge for healthcare systems worldwide. In the US, according to data from the American Red Cross, a mere 3% of citizens normally donate blood even though 38% of the population are eligible to donate; Every two seconds, someone requires a transfusion; And a single donation could save as many as three lives. The current US…

Recent Literature about Hemopure (HBOC-201)

  A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: Outcomes during severe anemia when transfusion is not an option. Zumberg M, Gorlin J, Griffiths EA, et al. Transfusion. 2020. March (Article in press)   Renal Protection Against Ischemia Reperfusion Injury: Hemoglobin-based Oxygen Carrier-201 Versus Blood as an Oxygen Carrier in Ex Vivo Subnormothermic Machine Perfusion. Bhattacharjee RN, Patel…